IBDEI1BR ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21413,1,4,0)
 ;;=4^N05.0
 ;;^UTILITY(U,$J,358.3,21413,2)
 ;;=^5015541
 ;;^UTILITY(U,$J,358.3,21414,0)
 ;;=N05.8^^70^917^23
 ;;^UTILITY(U,$J,358.3,21414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21414,1,3,0)
 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
 ;;^UTILITY(U,$J,358.3,21414,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,21414,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,21415,0)
 ;;=N18.6^^70^917^4
 ;;^UTILITY(U,$J,358.3,21415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21415,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,21415,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,21415,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,21416,0)
 ;;=R59.9^^70^918^4
 ;;^UTILITY(U,$J,358.3,21416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21416,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,21416,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,21416,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,21417,0)
 ;;=R59.1^^70^918^2
 ;;^UTILITY(U,$J,358.3,21417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21417,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,21417,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,21417,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,21418,0)
 ;;=R59.0^^70^918^3
 ;;^UTILITY(U,$J,358.3,21418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21418,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,21418,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,21418,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,21419,0)
 ;;=D64.9^^70^918^1
 ;;^UTILITY(U,$J,358.3,21419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21419,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,21419,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,21419,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,21420,0)
 ;;=R79.9^^70^919^1
 ;;^UTILITY(U,$J,358.3,21420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21420,1,3,0)
 ;;=3^Abnormal Finding of Blood Chemistry,Unspec
 ;;^UTILITY(U,$J,358.3,21420,1,4,0)
 ;;=4^R79.9
 ;;^UTILITY(U,$J,358.3,21420,2)
 ;;=^5019594
 ;;^UTILITY(U,$J,358.3,21421,0)
 ;;=R78.71^^70^919^2
 ;;^UTILITY(U,$J,358.3,21421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21421,1,3,0)
 ;;=3^Abnormal Lead Level in Blood
 ;;^UTILITY(U,$J,358.3,21421,1,4,0)
 ;;=4^R78.71
 ;;^UTILITY(U,$J,358.3,21421,2)
 ;;=^5019586
 ;;^UTILITY(U,$J,358.3,21422,0)
 ;;=R79.0^^70^919^3
 ;;^UTILITY(U,$J,358.3,21422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21422,1,3,0)
 ;;=3^Abnormal Level of Blood Mineral
 ;;^UTILITY(U,$J,358.3,21422,1,4,0)
 ;;=4^R79.0
 ;;^UTILITY(U,$J,358.3,21422,2)
 ;;=^5019590
 ;;^UTILITY(U,$J,358.3,21423,0)
 ;;=R78.79^^70^919^4
 ;;^UTILITY(U,$J,358.3,21423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21423,1,3,0)
 ;;=3^Abnormal Level of Heavy Metals in Blood
 ;;^UTILITY(U,$J,358.3,21423,1,4,0)
 ;;=4^R78.79
 ;;^UTILITY(U,$J,358.3,21423,2)
 ;;=^5019587
 ;;^UTILITY(U,$J,358.3,21424,0)
 ;;=E79.0^^70^919^10
 ;;^UTILITY(U,$J,358.3,21424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21424,1,3,0)
 ;;=3^Hyperuricemia w/o Signs of Inflam Arthrit/Tophaceous Disease
 ;;^UTILITY(U,$J,358.3,21424,1,4,0)
 ;;=4^E79.0
 ;;^UTILITY(U,$J,358.3,21424,2)
 ;;=^5002978
 ;;^UTILITY(U,$J,358.3,21425,0)
 ;;=K74.69^^70^919^5
 ;;^UTILITY(U,$J,358.3,21425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21425,1,3,0)
 ;;=3^Cirrhosis of Liver NEC
 ;;^UTILITY(U,$J,358.3,21425,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,21425,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,21426,0)
 ;;=K74.60^^70^919^6
